The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19
iScience. 2024 Dec 27;28(2):111698. doi: 10.1016/j.isci.2024.111698. eCollection 2025 Feb 21. ABSTRACT The severity of COVID 19 symptoms has a direct correlation with lymphopenia, affecting natural …